Pharmacological characterizations of the 'legal high' fluorolintane and isomers

MLA

Wallach, Jason, et al. “Pharmacological Characterizations of the ‘Legal High’ Fluorolintane and Isomers.” European Journal of Pharmacology, vol. 857, Aug. 2019, p. 172427. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....354c330c5dc3f8907040764dc6edf15a&authtype=sso&custid=ns315887.

APA

Wallach, J., Colestock, T., Agramunt, J., Claydon, M., Dybek, M., Filemban, N., Chatha, M., Halberstadt, A. L., Brandt, S., Lodge, D., Bortolotto, Z. A., & Adejare, A. (2019). Pharmacological characterizations of the “legal high” fluorolintane and isomers. European Journal of Pharmacology, 857, 172427.

Chicago

Wallach, Jason, Tristan Colestock, Julià Agramunt, Matt Claydon, Michael Dybek, Nathalie Filemban, Muhammad Chatha, et al. 2019. “Pharmacological Characterizations of the ‘Legal High’ Fluorolintane and Isomers.” European Journal of Pharmacology 857 (August): 172427. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....354c330c5dc3f8907040764dc6edf15a&authtype=sso&custid=ns315887.